Trend in Prevalence of Hepatitis B Virus Infection Among Blood Donor Individuals: An Eleven‑year of Experience in Lorestan, Iran

Abbas Ahmadi Vasmehjani, Sajad Yaghubi, Yousef Erfani, Zamaneh Hajikhezri, Mohammad Farahmand, Mohammad Shayestehpour, Omid Ali Adeli, Maryam Beiranvand

Abstract


Background: Hepatitis B virus is one of the transfusion transmissible infections. Despite the availability of hepatitis B virus (HBV) vaccine and screening tests but still danger of virus transmission via blood transfusion is high in some regions. The objective of this study was to determine the trend of seroprevalence of hepatitis B in over an 11‑year period (2005–2015). Methods: In this study, 355,083 blood donors were estimated for hepatitis B surface antigen (HBs Ag) seropositivity during 2005–2015 who referred to blood infusion centers of Lorestan province. Third‑generation ELISA method was used to detect HBs Ag. Results: The prevalence of HBs Ag in blood donors was 0.29% (1017). It was decreased steadily from 2005 to 2015 (0.68% to 0.12%) but increased in 2008 year. The trend prevalence of HBs Ag seropositivity significantly decreased over the study period (P < 0.001). The decline in HBV infection rates was more prominent in regular and repeated donor’s groups compared to people who donated blood for the first time (P < 0.001). Conclusions: The result of present study was indicated, Lorestan city in west of Iran can be classified as a low‑income region because the low prevalence of HBs Ag in blood donors. Also the prevalence of HBs Ag in first‑time donors was higher than other groups.

Keywords


Blood donors; hepatitis B; Lorestan; prevalence; trend

Full Text:

PDF

References


Abbas Z, Siddiqui AR. Management of hepatitis B in developing

countries. World J Hepatol 2011;3:292‑9.

Candotti D, Allain J‑P. Transfusion‑transmitted hepatitis B virus

infection. J Hepatol 2009;51:798‑809.

Hosseini SM, Tabaraei B, Hadadian S, Yavari F, Kamali Jamil R,

Shayestehpour M, et al. Increased the specificity and sensitivity

of monospecific antibody against host cell protein (HCP) in

quality control of hepatitis B recombinant vaccine. J Paramed

Sci 2011;2:24‑9.

Lavanchy D, Kane M. Global Epidemiology of Hepatitis B Virus

Infection. Hepatitis B Virus in Human Diseases. Springer; 2016.

p. 187‑203.

André F. Hepatitis B epidemiology in Asia, the middle East and

Africa. Vaccine 2000;18:S20‑2.

Ott J, Stevens G, Groeger J, Wiersma S. Global

epidemiology of hepatitis B virus infection: New estimates of

age‑specific HBsAg seroprevalence and endemicity. Vaccine

;30:2212‑9.

Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ.

Estimations of worldwide prevalence of chronic hepatitis B virus

infection: A systematic review of data published between 1965

and 2013. Lancet 2015;386:1546‑55.

Merat S, Rezvan H, Nouraie M, Jamali J, Assari S,

Abolghasemi H, et al. The prevalence of hepatitis B

surface antigen and anti‑hepatitis B core antibody in Iran:

A population‑based study. Arch Iran Med 2009;12:225‑31.

Zali MR. Epidemiology of hepatitis B in the Islamic Republic of

Iran. East Mediterr Health J 1996;2:290‑8.

Salehi‑Vaziri M, Sadeghi F, Hashiani AA, Fesharaki MG,

Alavian SM. Hepatitis B virus infection in the general population

of Iran: An updated systematic review and meta‑analysis. Hepat

Mon 2016;16:e35577.

Mohebbi SR, Sanati A, Cheraghipour K, Nejad MR,

Shalmani HM, Zali MR. Hepatitis C and hepatitis B virus

infection: Epidemiology and risk factors in a large cohort

of pregnant women in Lorestan, West of Iran. Hepat Mon

;11:736‑9.

Nazer MR, Obeidavi Z, Garmsiri M, Darvishi M, Taherian SP,

Nouruzi S. The prevalence rate of human immunodeficiency

virus co‑infection in HBV and HCV positive patients in

Lorestan province: A single referral center experience. Int J Adv

Biotechnol Res 2017;8:842‑8.

Doosti‑Irani A, Mokhaeri H, Sharafi AC, Aghasadeghi MR,

Hajimiragha M, Saki M, et al. Prevalence of HIV, HBV, and

HCV and related risk factors amongst male homeless people

in Lorestan province, the west of Iran. J Res Health Sci

;17:e00373.

Durro V, Qyra S. Trends in prevalence of hepatitis B virus

infection among Albanian blood donors, 1999‑2009. Virol J

;8:96.

Farshadpour F, Taherkhani R, Tajbakhsh S, Tangestani MG,

Hajiani G, Sharifi N, et al. Prevalence and trends of

transfusion‑Transmissible viral infections among blood donors

in south of Iran: An Eleven‑Year retrospective study. PloS One

;11:e0157615.

Yuen MF, Ka‑Ho Wong D, Lee CK, Tanaka Y, Allain JP, Fung J,

et al. Transmissibility of hepatitis B virus (HBV) infection

through blood transfusion from blood donors with occult HBV

infection. Clin Infect Dis 2011;52:624‑32.

Alavian SM. Hepatitis B virus infection in Iran; Changing the

epidemiology. Arch Clin Infec Dis 2010;5:51‑61.

Babanejad M, Izadi N, Najafi F, Alavian SM. The HBsAg

prevalence among blood donors from Eastern Mediterranean

and Middle Eastern countries: A systematic review and

meta‑Analysis. Hepat Mon 2016;16:e35664.

Amini Kafi-abad S, Rezvan H, Abolghasemi H, Talebian A.

Prevalence and trends of human immunodeficiency virus,

hepatitis B virus, and hepatitis C virus among blood donors in

Iran, 2004 through 2007. Transfusion 2009;49:2214‑20.

Mohammadali F, Pourfathollah AA. Changes in frequency of

HBV, HCV, HIV and syphilis infections among blood donors

in Tehran province 2005‑2011. Arch Iran Med 2014;17:613‑20.

Boustani H, Anvari E, Saiadi Sartang S, Omidi M, Rostami E,

Mohamadi Z. Prevalence of HIV, hepatitis B and C infections

among volunteer blood donors at the blood transfusion center of

Ilam city, Iran. J Basic Res Med Sci 2017;4:4‑8.

Kafi-Abad SA, Rezvan H, Abolghasemi H. Trends in prevalence

of hepatitis B virus infection among Iranian blood donors,

‑2007. Transfus Med 2009;19:189‑94.

Sayad B, Foroughikia M, Akramipour R, Farokhi A, Mansouri F,

Janbakhsh A, et al. Hepatitis B, hepatitis C, and human

immunodeficiency virus infection in multi‑transfused thalassemic

patients, Kermanshah, Iran, 2015. Jundishapur J Microbiol

;10:1-5.

Farzadegan H, Harbour C, Ala F. The prevalence of hepatitis B

surface antigen and its antibody in blood donors and high risk

groups in Iran. Vox Sang 1979;37:182‑6.

Norouzian H, Gholami M, Shakib P, Goudarzi G, Diali HG,

Rezvani A. Prevalence of HCV infections and co‑infection with

HBV and HIV and associated risk factors among addicts in Drug

Treatment Centers, Lorestan Province, Iran. Int J High Risk

Behav Addict 2016;5:e25028.

Tessema B, Yismaw G, Kassu A, Amsalu A, Mulu A, Emmrich F,

et al. Seroprevalence of HIV, HBV, HCV and syphilis infections

among blood donors at Gondar University Teaching Hospital,

Northwest Ethiopia: Declining trends over a period of five years.

BMC Infect Dis 2010;10:111.

Ranjbarian P. Comparison of positive HBsAg prevalence in

first‑time, repeat, and regular blood donors for the purpose of

selecting donors in Hamedan Blood Transfusion Center. Sci J

Blood Transfus Organ 2008;4:359‑63.

Poorolajal J, Majdzadeh R. Prevalence of chronic hepatitis B

infection in Iran: A review article. J Res Med Sci 2009;14:249‑58.

Masaeli Z, Jaberi M, Magsudlu M. A comparison of

seroprevalence of blood‑borne infections among regular,

sporadic, and first‑time blood donors in Isfahan. Sci J Blood

Transfus Org 2006;2:301‑7.




ijpm_12_448